Provided by Tiger Trade Technology Pte. Ltd.

HCW Biologics Inc.

1.71
-0.0400-2.29%
Post-market: 1.710.00000.00%19:59 EDT
Volume:48.41K
Turnover:83.99K
Market Cap:3.14M
PE:-0.06
High:1.82
Open:1.77
Low:1.71
Close:1.75
52wk High:29.28
52wk Low:1.50
Shares:1.84M
Float Shares:1.65M
Volume Ratio:0.02
T/O Rate:2.93%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-27.1846
EPS(LYR):-63.7804
ROE:-151.36%
ROA:-13.88%
PB:0.42
PE(LYR):-0.03

Loading ...

Hcw Biologics Inc trading halted, news pending

TIPRANKS
·
Jun 30

HCW Biologics Effects 1-for-6 Reverse Stock Split June 30

Reuters
·
Jun 26

HCW Biologics Announces 1-for-6 Reverse Stock Split Effective on June 30, 2026

THOMSON REUTERS
·
Jun 26

HCW Biologics Reports Positive Phase 1 Alopecia Trial Data

TIPRANKS
·
Jun 16

HCW Biologics announces data from first two dose cohorts of HCW9302 trial

TIPRANKS
·
Jun 16

HCW Biologics says Phase 1 trial shows hair regrowth signals for HCW9302 in alopecia areata patients

Reuters
·
Jun 16

HCW Biologics Announces Positive Results for Preliminary Human Data Readout for Phase 1 Clinical Trial Evaluating Il-2 Based Fusion Immunotherapeutic, HCW9302 Monotherapy, in Alopecia Areata

THOMSON REUTERS
·
Jun 16

HCW Biologics - All Participants in 3 Mcg/Kg Cohort Show Positive Response After Single Dose

THOMSON REUTERS
·
Jun 16

HCW Biologics - to Establish Recommended Phase 2 Dose by Year End 2026

THOMSON REUTERS
·
Jun 16

HCW Biologics - Treatment of Third Dose Cohort (8 Mcg/Kg) Underway in Phase 1 Trial

THOMSON REUTERS
·
Jun 16

HCW Biologics - HCW9302 Well Tolerated With No Dose-Limiting Toxicities Reported

THOMSON REUTERS
·
Jun 16

HCW Biologics Announces Positive Results for Preliminary Human Data Readout for Phase 1 Clinical Trial Evaluating IL-2 Based Fusion Immunotherapeutic, HCW9302 Monotherapy, in Alopecia Areata

GlobeNewswire
·
Jun 16

HCW Biologics Shareholders Approve Governance and Capital Measures

TIPRANKS
·
Jun 16

HCW Biologics shareholders approve reverse stock split proposal at annual meeting

Reuters
·
Jun 16

HCW Biologics Registers Resale of Up to 5.7 Million Shares

MT Newswires Live
·
Jun 08

BRIEF-HCW Biologics Proposed Resale Of Up To 5.69 Million Shares Of Common Stock

Reuters
·
Jun 08

HCW Biologics registers to sell 5.69M shares of common stock for holders

TIPRANKS
·
Jun 08

HCW Biologics - Proposed Resale of up to 5.69 Mln Shares of Common Stock - SEC Filing

THOMSON REUTERS
·
Jun 08

HCW Biologics Wins Nasdaq Extension to Avoid Delisting

TIPRANKS
·
Jun 01

HCW Biologics gets Nasdaq extension to regain $1 minimum bid compliance by July 29

Reuters
·
Jun 01